Literature DB >> 25581668

Treatment of warts with contact allergens.

Andrew P Word1, Kaveh A Nezafati, Ponciano D Cruz.   

Abstract

Contact immunotherapy is an increasingly used, effective means of treating cutaneous viral warts. Dinitrochlorobenzene, diphencyprone, and squaric acid dibutylester are the most frequently used modalities, showing slight variances in adverse effect profiles and efficacy. All of these agents serve as safe treatment modalities when administered according to the guidelines recommended herein. We review the value of contact immunotherapy in the treatment of cutaneous viral warts.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25581668     DOI: 10.1097/DER.0000000000000092

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  6 in total

Review 1.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

2.  Diphenciprone as a therapeutic alternative to exuberant periungual warts.

Authors:  Bruno de Castro E Souza; Caroline Paias Ribeiro; Bethânia Cabral Cavalli Swiczar; Mário Cezar Pires
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

Review 3.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

4.  A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.

Authors:  Lana Kandalaft; Ananda Mookerjee; Michele Graciotti
Journal:  Bioimpacts       Date:  2018-06-10

5.  Anaphylaxis to diphenylcyclopropenone during sensitization for wart treatment-A case report.

Authors:  Kavya Venkatesh; James Yun; Sophie Bakis-Petsoglou
Journal:  JAAD Case Rep       Date:  2018-10-03

6.  Characterizing Adduct Formation of Electrophilic Skin Allergens with Human Serum Albumin and Hemoglobin.

Authors:  Lorena Ndreu; Luke N Erber; Margareta Törnqvist; Natalia Y Tretyakova; Isabella Karlsson
Journal:  Chem Res Toxicol       Date:  2020-09-17       Impact factor: 3.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.